We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
-24.17%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
10 Year Est. Return
AUM
$53M
AUM Growth
-$27.8M
Cap. Flow
-$6.47M
Cap. Flow %
-12.21%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AUTL
Autolus Therapeutics
AUTL
+$6.47M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$386M
$39.1M 73.83%
16,640,720
-1,913,904
-10% -$6.47M
ACHL
2
DELISTED
Achilles Therapeutics
ACHL
$12.6M 23.86%
11,086,909
IPSC icon
3
Century Therapeutics
IPSC
$381M
$1.23M 2.31%
1,213,056

Similar funds

Syncona Portfolio's Q4 2024 Portfolio in Review

As of Q4 2024, Syncona Portfolio held 3 positions worth $53M, down 34% from $80.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syncona Portfolio withdrew a net $6.47M in Q4 2024, reducing 1 holding. Its largest reduction was Autolus Therapeutics, cutting an estimated $6.47M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio's biggest Q4 2024 reduction was Autolus Therapeutics, cutting an estimated $6.47M.
  • Syncona Portfolio's ten largest holdings make up 100% of its $53M portfolio in Q4 2024.
  • Syncona Portfolio opened 0 new positions and closed 0 in Q4 2024.
  • Syncona Portfolio's portfolio value fell 34% quarter-over-quarter to $53M.

Based on Syncona Portfolio's 13F filing for Q4 2024, filed 6 Feb 2025.